a&#45

An Open Label, Randomized, Two-Treatment, Four-Period, Two-Sequence, Single Oral Dose, Crossover, Fully Replicate Bioequivalence Study of SEDRONATE (35 mg) (Risedronate Sodium 35 mg Tablets) of the Government Pharmaceutical Organization, Thailand with Actonel Once-a-Week 35 mg (Risedronate Sodium 35 mg Tablets) of Norwich Pharmaceuticals, Inc., United States of America in Normal, Healthy, Adult Human Subjects under Fasting Conditions

An Open Label, Randomized, Two-Treatment, Two-Period, Two-Sequence, Single Oral Dose, Crossover Bioequivalence Study of GPO-A-FLU (Oseltamivir 6 mg/ml powder for oral suspension) of The Government Pharmaceutical Organization, Thailand with Tamiflu (Oseltamivir 6 mg/ml powder for oral suspension) of Rottendorf Pharma GmbH, Germany, in Normal, Healthy, Adults Human Subjects under Fasting Conditions